In addition to Fleetwood Phase III, the foundation will also collaborate with Lapane on an AHRQ-funded study of GRAM, an innovative clinical tool that identifies medications that may cause or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback